50 /100
MEDIUM RISK
Score updated Feb 27, 2026
KPTI
Karyopharm Therapeutics Inc.

DilutionScore™ measures dilution risk across 5 factors. Lower scores indicate higher risk of share dilution.

🔔 Get alerts when KPTI's score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
60
📊 Float Risk
70
⚠️ Warrant Exposure
85
🔄Convertible Debt
💹 Market Data
Market Cap$172.62M
Shares Outstanding18.34M
Float16.30M
Cash$63.74M
Debt$305.94M
Short InterestN/A
🏛 Institutional Holdings
54 institutional holders · 3.47M shares
#1 T. Rowe Price Investment Management, Inc. 701.0K shares
#2 ADAGE CAPITAL PARTNERS GP, L.L.C. 421.3K shares
#3 VANGUARD GROUP INC 408.2K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest743.7K
Days to Cover1.5
% of Float4.6%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account
📰 Recent News
Track KPTI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KPTI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required